Literature DB >> 2134637

Leukocyte-poor blood components: a purer and safer transfusion product for recipients?

P Rebulla1, F Bertolini, A Parravicini, G Sirchia.   

Abstract

Mesh：

Year:  1990        PMID： 2134637     DOI： 10.1016/s0887-7963(90)70238-6

Source DB:  PubMed          Journal:  Transfus Med Rev        ISSN： 0887-7963


× No keyword cloud information.
  2 in total

1.  Leukoreduced blood components: Advantages and strategies for its implementation in developing countries.

Authors:  R R Sharma; Neelam Marwaha
Journal:  Asian J Transfus Sci       Date:  2010-01

2.  Understanding loss of donor white blood cell immunogenicity after pathogen reduction: mechanisms of action in ultraviolet illumination and riboflavin treatment.

Authors:  Rachael P Jackman; John W Heitman; Susanne Marschner; Raymond P Goodrich; Philip J Norris
Journal:  Transfusion       Date:  2009-08-04       Impact factor: 3.157
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.